1. Dual Merger Review Requires Separate Us and Eu Analysis
A New York company pursuing a cross-border acquisition may face merger review in both the United States and European Union. Each system has separate jurisdictional rules, filing procedures, and substantive standards. Transaction planning should identify potential filing obligations before the parties commit to a closing schedule.
Why Parallel Review Matters for New York Companies
A transaction may affect markets, customers, assets, or operations in several jurisdictions. U.S. .learance does not satisfy EU merger control requirements, and an EU decision does not replace applicable U.S. .eview.
Deal teams should map each jurisdiction that may review the transaction. They should also identify the information and approvals required before closing.
Different Authorities and Review Frameworks
In the United States, the DOJ Antitrust Division and FTC share federal merger enforcement responsibilities. HSR filings go to both agencies, but one agency generally takes responsibility for reviewing the transaction.
In the European Union, the European Commission reviews qualifying concentrations under the EU merger control framework. The systems may examine overlapping concerns while applying distinct jurisdictional requirements and procedures.
2. The Us Merger Process Begins with Hsr Analysis
The Hart-Scott-Rodino Act requires premerger notification for transactions that satisfy applicable statutory and regulatory requirements. Reportability depends on the transaction and the rules in effect at the time. Parties should also examine available exemptions before concluding that an HSR filing is required.
A completed HSR filing generally starts a 30-day waiting period. The period is 15 days for a cash tender offer or a qualifying bankruptcy transaction. The parties generally may not close during that period unless the agencies grant early termination.
Determine Whether an Hsr Filing Is Required
HSR analysis should begin early enough to fit the filing process into the transaction timetable. Transaction value, structure, the parties, and applicable exemptions can affect reportability.
Thresholds change over time, so figures from an earlier deal may no longer apply. The filing analysis should use the requirements and filing materials in effect for the current transaction.
Prepare for a Possible Second Request
After preliminary review, the reviewing agency may request additional information and documentary material. A Second Request can substantially expand the documents, data, and business information required from the parties.
New York companies should identify likely custodians, transaction records, strategic materials, and competition analyses before an intensive review develops. Document collection plans should also account for systems holding potentially responsive material.
3. Eu Dg Comp Review Follows a Separate Merger Control Process
U.S. .usinesses with European operations should not treat HSR compliance as the end of merger-control analysis. A qualifying concentration may also require notification to the European Commission. EU review belongs in the transaction plan while remaining legally distinct from U.S. .eview.
Assess Eu Filing Obligations before Closing
The EU Merger Regulation contains jurisdictional criteria for determining whether a concentration falls within the European Commission's authority. Transaction structure and relevant turnover information require careful review when assessing those criteria.
Deal teams should gather the corporate and financial information needed for that analysis early. A related EU competition law review can identify additional issues relevant to transaction planning.
Distinguish Phase I from Phase Ii Review
The European Commission begins its substantive review after notification in Phase I. That initial review generally lasts 25 working days. A transaction that continues to raise competition concerns may proceed to an in-depth Phase II investigation, which generally lasts 90 working days and may be extended.
Deeper review may require additional evidence, economic analysis, internal records, and engagement with the Commission. The deal timetable should account for that possibility rather than assume clearance during the initial review.
4. Concurrent Reviews Need One Factual Record and Two Legal Analyses
Parallel U.S. .nd EU reviews create a practical coordination challenge. The parties may address the same transaction, markets, competitors, customers, and efficiencies before different authorities. Factual consistency matters even when legal standards and procedures differ.
Coordinate Transaction Evidence Across Jurisdictions
Internal documents may become significant in both reviews. Strategic plans, board materials, market analyses, customer information, pricing records, and transaction presentations deserve coordinated review.
Ordinary business documents may later receive close regulatory attention. Deal teams should keep descriptions of competitors, market conditions, and expected transaction effects accurate and grounded in available information.
Manage Timing without Assuming Identical Outcomes
Closing conditions should account for the approvals actually required by the transaction. U.S. .nd EU reviews may progress differently or focus on different competitive concerns.
The legal team should track filings, information requests, regulatory communications, and potential remedies across both processes. A coordinated merger clearance review can help management assess regulatory developments that may affect closing.
5. Remedy Discussions Can Affect Deal Structure and Closing Risk
Competition concerns identified during review may lead to discussions about potential remedies. The appropriate response depends on the authority, transaction, competitive theory, and evidence. A remedy acceptable in one jurisdiction does not automatically resolve concerns in another.
Structural and Behavioral Remedies Require Deal-Specific Review
Potential remedies may involve divestitures or commitments concerning future business conduct. Their feasibility depends on the assets, markets, competitive concerns, and requirements of the reviewing authority.
A proposed divestiture may also affect financing, valuation, integration planning, and the commercial rationale for the deal. Business teams need to assess those consequences alongside the competition analysis.
Divergent Regulatory Concerns Need Coordination
The DOJ and European Commission may examine similar evidence without reaching identical procedural or remedial positions. A coordinated strategy should preserve the legal distinctions between the two reviews.
Management also needs to consider how proposed concessions in one jurisdiction could affect positions elsewhere. Broader antitrust law analysis can identify related competition issues before positions are presented to regulators.
6. Transaction Teams Should Prepare for Review before Filing
Merger control planning should begin before filing deadlines dominate the transaction. The team needs to identify reportability, competition issues, key documents, responsible employees, and information required across jurisdictions.
Build a Cross-Border Review Team Early
U.S. .ntitrust attorneys and EU competition lawyers may need to coordinate with corporate attorneys, economists, finance teams, and business personnel. Defined responsibilities reduce inconsistent instructions and duplicate information requests.
A legal due diligence review can help organize transaction records and identify issues requiring further analysis. Senior management should receive focused updates on material regulatory developments.
Escalate Competition Concerns before They Delay the Deal
Potential concerns deserve attention when parties compete closely or internal records predict reduced competition. Market definition, entry, competitive effects, or remedy questions may also become central during review.
Early escalation does not establish that a transaction violates competition law. It gives the parties time to test evidence, evaluate legal theories, and align regulatory planning with the transaction timetable.
7. Frequently Asked Questions
Can the same New York acquisition require both HSR and EU merger filings?
A transaction may trigger review in both jurisdictions when the applicable requirements are satisfied. Each filing obligation requires separate analysis under the rules governing that transaction.
Does DOJ clearance mean the European Commission will also approve the merger?
No automatic rule links the outcomes. U.S. .nd EU authorities operate under separate legal frameworks, procedures, and jurisdictional requirements, even when they examine similar competitive issues.
What happens if a merger receives a Second Request and Phase II review?
The transaction may face detailed investigations in both jurisdictions. The parties may need to coordinate evidence, regulatory responses, potential remedies, and closing conditions while addressing each process separately.
Can a cross-border merger close before both U.S. and EU reviews are complete?
Closing generally depends on the HSR waiting period and, for a notifiable EU concentration, Commission clearance. Deal teams should identify each required clearance before setting or revising the closing timetable.
8. Coordinate U.S. and Eu Merger Review before Closing Decisions Harden
SJKP's attorneys assist companies with cross-border merger planning, HSR analysis, competition review, document preparation, regulatory responses, and transaction risk assessment. The firm's attorneys can coordinate U.S. .ntitrust issues with EU competition-law requirements while preserving the distinctions between each review. Companies preparing transactions with potential U.S. .nd EU filing obligations can contact SJKP to discuss legal and procedural issues that may affect approval and closing.
18 Aug, 2026
